In the present study, we focused on the impact of the HGF/MET pathway on Chk1 activity, taking into account previous findings of a role of the MET pathway in regulation of cell proliferation and cetuximab resistance in colon cancer cells [15, 27]. This evidence concerns the gene CHEK1 and malignant colon neoplasm.